INTRODUCTION: Hepatitis E virus (HEV) is an emerging cause of autochthonous-acute-hepatitis and acute-on-chronic-liver-failure in western countries. Treatment is not routinely used, despite ribavirin has a good antiviral effect. In vitro sofosbuvir inhibits HEV replication, but clinical data are lacking. CASE REPORT: We report a case of acute-on-chronic-liver-failure due to HEV treated with sofosbuvir and ribavirin. The treatment was capable of rapidly inducing both HCV and HEV viral suppression. CONCLUSION: In conclusion, although more data are required before firm conclusions could be drawn, the combination of sofosbuvir and ribavirin in not immunosuppressed patients with acute hepatitis E may be able to clear HEV infection.
INTRODUCTION:Hepatitis E virus (HEV) is an emerging cause of autochthonous-acute-hepatitis and acute-on-chronic-liver-failure in western countries. Treatment is not routinely used, despite ribavirin has a good antiviral effect. In vitro sofosbuvir inhibits HEV replication, but clinical data are lacking. CASE REPORT: We report a case of acute-on-chronic-liver-failure due to HEV treated with sofosbuvir and ribavirin. The treatment was capable of rapidly inducing both HCV and HEV viral suppression. CONCLUSION: In conclusion, although more data are required before firm conclusions could be drawn, the combination of sofosbuvir and ribavirin in not immunosuppressed patients with acute hepatitis E may be able to clear HEV infection.
Authors: Jean Marie Péron; Florence Abravanel; Maeva Guillaume; René Gérolami; Jean Nana; Rodolphe Anty; Alexandre Pariente; Christophe Renou; Christophe Bureau; Marie-Angèle Robic; Laurent Alric; Jean Pierre Vinel; Jacques Izopet; Nassim Kamar Journal: Liver Int Date: 2015-12-30 Impact factor: 5.828
Authors: Mhairi C Donnelly; Stuart N Imlach; Florence Abravanel; Sandeep Ramalingam; Ingolfur Johannessen; Juraj Petrik; Alistair R Fraser; John D M Campbell; Peter Bramley; Harry R Dalton; Peter C Hayes; Nassim Kamar; Kenneth J Simpson Journal: Gastroenterology Date: 2016-11-21 Impact factor: 22.682
Authors: J M Péron; C Bureau; H Poirson; J M Mansuy; L Alric; J Selves; E Dupuis; J Izopet; J P Vinel Journal: J Viral Hepat Date: 2007-05 Impact factor: 3.728
Authors: Viet Loan Dao Thi; Yannick Debing; Xianfang Wu; Charles M Rice; Johan Neyts; Darius Moradpour; Jérôme Gouttenoire Journal: Gastroenterology Date: 2015-09-25 Impact factor: 22.682
Authors: Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White Journal: Antimicrob Agents Chemother Date: 2019-05-24 Impact factor: 5.191